Selection of transposon mutants of Mycobacterium tuberculosis with increased macrophage infectivity identifies fadD23 to be involved in sulfolipid production and association with macrophages

References

1. Bardarov S., Kriakov J., Carriere C., Yu S., Vaamonde C., McAdam R. A., Bloom B. R., Hatfull G. F., Jacobs W. R. Jr 1997; Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 94:10961–10966
   [Google Scholar]
2. Bateman A., Coin L., Durbin R., Finn R. D., Hollich V., Griffiths-Jones S., Khanna A., Marshall M., Moxon S. other authors 2004; The Pfam protein families database. Nucleic Acids Res 32:D138–D141
   [Google Scholar]
3. Belisle J. T., Sonnenberg M. G. 1998; Isolation of genomic DNA from mycobacteria. In Methods in Molecular Biology: Mycobacteria Protocols pp 31–44 Edited by Parish T., Stoker N. G. Totowa, NJ: Humana Press;
   [Google Scholar]
4. Besra G. S. 1998; Preparation of cell wall fractions from mycobacteria. In Methods in Molecular Biology: Mycobacteria Protocols pp 91–107 Edited by Parish T., Stoker N. G. Totowa, NJ: Humana Press;
   [Google Scholar]
5. Camacho L. R., Ensergueix D., Perez E., Gicquel B., Guilhot C. 1999; Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 34:257–267
   [Google Scholar]
6. Cole S. T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S. V., Eiglmeier K., Gas S. other authors 1998; Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537–544
   [Google Scholar]
7. Converse S. E., Mougous J. D., Leavell M. D., Leary J. A., Bertozzi C. R., Cox J. S. 2003; MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc Natl Acad Sci U S A 100:6121–6126
   [Google Scholar]
8. Cox J. S., Chen B., McNeil M., Jacobs W. R. Jr 1999; Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402:79–83
   [Google Scholar]
9. Dobson G., Minnikin D. E., Minnkin S. M., Pharlett J. H., Goodfellow M., Ridell M., Magnusson M. 1985; Systematic analysis of complex mycobacterial lipids. In Chemical Methods in Bacterial Systematics pp 237–265 Edited by Goodfellow M., Minnikin D. E. London: Academic Press;
   [Google Scholar]
10. Domenech P., Reed M. B., Dowd C. S., Manca C., Kaplan G., Barry C. E. III 2004; The role of MmpL8 in sulfatide biogenesis and virulence of Mycobacterium tuberculosis. J Biol Chem 279:21257–21265
    [Google Scholar]
11. Dubey V. S., Sirakova T. D., Kolattukudy P. E. 2002; Disruption of msl3 abolishes the synthesis of mycolipanoic and mycolipenic acids required for polyacyltrehalose synthesis in Mycobacterium tuberculosis H37Rv and causes cell aggregation. Mol Microbiol 45:1451–1459
    [Google Scholar]
12. Dullaghan E. M., Malloff C. A., Li A. H., Lam W. L., Stokes R. W. 2002; Two-dimensional bacterial genome display: a method for the genomic analysis of mycobacteria. Microbiology 148:3111–3117
    [Google Scholar]
13. El-Etr S. H., Cirillo J. D. 2001; Entry mechanisms of mycobacteria. Front Biosci 6:D737–D747
    [Google Scholar]
14. Ernst J. D. 1998; Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 66:1277–1281
    [Google Scholar]
15. Espinal M. A. 2003; The global situation of MDR-TB. Tuberculosis (Edinb 83:44–51
    [Google Scholar]
16. Etienne G., Villeneuve C., Billman-Jacobe H., Astarie-Dequeker C., Dupont M. A., Daffe M. 2002; The impact of the absence of glycopeptidolipids on the ultrastructure, cell surface and cell wall properties, and phagocytosis of Mycobacterium smegmatis. Microbiology 148:3089–3100
    [Google Scholar]
17. Garcia de Viedma D., Lorenzo G., Cardona P. J., Alonso Rodriguez N., Gordillo S., Ruiz Serrano M. J., Bouza E. 2005; Association between the infectivity of Mycobacterium tuberculosis strains and their efficiency for extrarespiratory infection. J Infect Dis 192:2059–2065
    [Google Scholar]
18. Hisert K. B., Kirksey M. A., Gomez J. E., Sousa A. O., Cox J. S., Jacobs W. R. Jr, Nathan C. F., McKinney J. D. 2004; Identification of Mycobacterium tuberculosis counterimmune ( cim) mutants in immunodeficient mice by differential screening. Infect Immun 72:5315–5321
    [Google Scholar]
19. Jain M., Petzold C. J., Schelle M. W., Leavell M. D., Mougous J. D., Bertozzi C. R., Leary J. A., Cox J. S. 2007; Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling. Proc Natl Acad Sci U S A 104:5133–5138
    [Google Scholar]
20. McAdam R. A., Quan S., Smith D. A., Bardarov S., Betts J. C., Cook F. C., Hooker E. U., Lewis A. P., Woollard P. other authors 2002; Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulence. Microbiology 148:2975–2986
    [Google Scholar]
21. Nunn P., Williams B., Floyd K., Dye C., Elzinga G., Raviglione M. 2005; Tuberculosis control in the era of HIV. Nat Rev Immunol 5:819–826
    [Google Scholar]
22. Ormerod L. P. 2005; Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull 73:7417–24
    [Google Scholar]
23. Parish T., Stoker N. G. 1998; Electroporation of mycobacteria. In Methods in Molecular Biology: Mycobacteria Protocols pp 129–144 Edited by Parish T., Stoker N. G. Totowa, NJ: Humana Press;
    [Google Scholar]
24. Raetz C. R., Roderick S. L. 1995; A left-handed parallel β helix in the structure of UDP- N-acetylglucosamine acyltransferase. Science 270:997–1000
    [Google Scholar]
25. Raviglione M. C. 2003; The TB epidemic from 1992 to 2002. Tuberculosis (Edinb 83:4–14
    [Google Scholar]
26. Rousseau C., Neyrolles O., Bordat Y., Giroux S., Sirakova T. D., Prevost M. C., Kolattukudy P. E., Gicquel B., Jackson M. 2003; Deficiency in mycolipenate- and mycosanoate-derived acyltrehaloses enhances early interactions of Mycobacterium tuberculosis with host cells. Cell Microbiol 5:405–415
    [Google Scholar]
27. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
28. Sassetti C. M., Rubin E. J. 2003; Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A 100:12989–12994
    [Google Scholar]
29. Sassetti C. M., Boyd D. H., Rubin E. J. 2003; Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48:77–84
    [Google Scholar]
30. Sirakova T. D., Thirumala A. K., Dubey V. S., Sprecher H., Kolattukudy P. E. 2001; The Mycobacterium tuberculosis pks2 gene encodes the synthase for the hepta- and octamethyl-branched fatty acids required for sulfolipid synthesis. J Biol Chem 276:16833–16839
    [Google Scholar]
31. Smith R. J., Iden S. S. 1981; Properties of calcium ionophore-induced generation of superoxide anion by human neutrophils. Inflammation 5:177–192
    [Google Scholar]
32. Soto C. Y., Cama M., Gibert I., Luquin M. 2000; Application of an easy and reliable method for sulfolipid-1 detection in the study of its distribution in Mycobacterium tuberculosis strains. FEMS Microbiol Lett 187:103–107
    [Google Scholar]
33. Stewart G. R., Patel J., Robertson B. D., Rae A., Young D. B. 2005; Mycobacterial mutants with defective control of phagosomal acidification. PLoS Pathog 1:269–278
    [Google Scholar]
34. Stokes R. W., Doxsee D. 1999; The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages. Cell Immunol 197:1–9
    [Google Scholar]
35. Stokes R. W., Orme I. M., Collins F. M. 1986; Role of mononuclear phagocytes in expression of resistance and susceptibility to Mycobacterium avium infections in mice. Infect Immun 54:811–819
    [Google Scholar]
36. Stokes R. W., Norris-Jones R., Brooks D. E., Beveridge T. J., Doxsee D., Thorson L. M. 2004; The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages. Infect Immun 72:5676–5686
    [Google Scholar]
37. Stover C. K., de la Cruz V. F., Fuerst T. R., Burlein J. E., Benson L. A., Bennett L. T., Bansal G. P., Young J. F., Lee M. H. other authors 1991; New use of BCG for recombinant vaccines. Nature 351:456–460
    [Google Scholar]
38. Takayama K., Schnoes H. K., Armstrong E. L., Boyle R. W. 1975; Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. J Lipid Res 16:308–317
    [Google Scholar]
39. Trivedi O. A., Arora P., Sridharan V., Tickoo R., Mohanty D., Gokhale R. S. 2004; Enzymic activation and transfer of fatty acids as acyl-adenylates in mycobacteria. Nature 428:441–445
    [Google Scholar]
40. Villeneuve C., Etienne G., Abadie V., Montrozier H., Bordier C., Laval F., Daffe M., Maridonneau-Parini I., Astarie-Dequeker C. 2003; Surface-exposed glycopeptidolipids of Mycobacterium smegmatis specifically inhibit the phagocytosis of mycobacteria by human macrophages. Identification of a novel family of glycopeptidolipids. J Biol Chem 278:51291–51300
    [Google Scholar]
41. Vuorio R., Harkonen T., Tolvanen M., Vaara M. 1994; The novel hexapeptide motif found in the acyltransferases LpxA and LpxD of lipid A biosynthesis is conserved in various bacteria. FEBS Lett 337:289–292
    [Google Scholar]
42. Waddell S. J., Chung G. A., Gibson K. J. C., Everett M. J., Minnikin D. E., Besra G. S., Butcher P. D. 2005; Inactivation of polyketide synthase and related genes results in the loss of complex lipids in Mycobacterium tuberculosis H37Rv. Lett Appl Microbiol 40:201–206
    [Google Scholar]
43. Wenzel C. Q., Daniels C., Keates R. A., Brewer D., Lam J. S. 2005; Evidence that WbpD is an N-acetyltransferase belonging to the hexapeptide acyltransferase superfamily and an important protein for O-antigen biosynthesis in Pseudomonas aeruginosa PAO1. Mol Microbiol 57:1288–1303
    [Google Scholar]